SciGen Pte Ltd. is the global commercial arm of Yifan Pharmaceutical Co. Ltd, an integrated pharmaceutical company engaged in R&D, production and commercialization of APIs and finished dosage forms. SciGen has commercialized several biotech products, namely Gensulin/Scilin, Scitropin A and Zometa, and will commercialize pipeline assets in diabetology, oncology and immunology, with key focus therapy areas including endocrinology, oncology, anti-infectives, immunology and hepatology; BIOTON, headquartered in Warsaw, Poland, is a European biotech company producing high-quality human insulin, offering both finished forms and the API, based on deep expertise in diabetology, an innovative approach and the highest quality standards, also offering R&D services and contract manufacturing.
No comments available.
Leave your rating & comment